InsiderClue
Insiders · Profile

Hindman Andrew A.

SVP, CHIEF FINANCIAL OFFICER at Theravance Biopharma. Filing since 18 Nov 2022. CIK 0001607965

Company
Date
Role
Action
Shares
Amount
Of holding
TBPH Theravance Biopharma, Inc.
18 Nov 2022
SVP, CHIEF FINANCIAL OFFICER
Sold, plan not stated
65,000
$716.24K
13.7%
1 decision on file.